TITLE

IL23R Arg38lGln is associated with childhood onset inflammatory bowel disease in Scotland

AUTHOR(S)
Van Limbergen, J.; Russell, R. K.; Nimmo, F. R.; Drummond, H. E.; Smith, L.; Davies, G.; Anderson, N. H.; P. M. Gillett; P. McGrogan; Hassan, K.; Weaver, I.; Bisset, W. M.; Mahdi, G.; Wilson, D. C.; Satsangi, J.
PUB. DATE
August 2007
SOURCE
Gut;Aug2007, Vol. 56 Issue 8, p1173
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor which offers information about the study designed to investigate the association of IL23R Arg381Gln with the childhood onset of inflammatory bowel disease in Scotland is presented.
ACCESSION #
25972159

 

Related Articles

  • Inflammatory Bowel Disease and ADAM17 Deletion.  // New England Journal of Medicine;1/12/2012, Vol. 366 Issue 2, p190 

    A letter to the editor is presented in response to an article on the loss-of-function mutation in ADAM17 in the October 20, 2011 issue.

  • Inflammatory Bowel Disease. Famularo, Giuseppe; Trinchieri, Vito; De Simone, Claudio // New England Journal of Medicine;12/12/2002, Vol. 347 Issue 24, p1982 

    A letter to the editor is presented in response to the article "Inflammatory Bowel Disease," by D.K. Podolsky in the August 8, 2002 issue.

  • Inflammatory Bowel Disease. Mohammed, Faiyaz // New England Journal of Medicine;12/12/2002, Vol. 347 Issue 24, p1982 

    A letter to the editor is presented in response to the article "Inflammatory Bowel Disease," by D.K. Podolsky in the August 8, 2002 issue.

  • Inflammatory Bowel Disease. Podolsky, Daniel K. // New England Journal of Medicine;12/12/2002, Vol. 347 Issue 24, p1982 

    A response by D.K. Podolsky to several letters to the editor about his article "Inflammatory Bowel Disease," in the August 8, 2002 issue is presented.

  • Selective Adhesion-Molecule Therapy and Inflammatory Bowel Disease. Chaudhuri, Abhijit // New England Journal of Medicine;2/9/2006, Vol. 354 Issue 6, p644 

    A letter to the editor is presented in response to an article on patients with inflammatory bowel disease, which was published in the November 3, 2005 issue.

  • Selective Adhesion-Molecule Therapy and Inflammatory Bowel Disease. Podolsky, Daniel K. // New England Journal of Medicine;2/9/2006, Vol. 354 Issue 6, p644 

    A response by author Daniel K. Podolsky is presented with reference to a letter to the editor on his article on patients with inflammatory bowel disease, which was published in the November 3, 2005 issue.

  • Electrocardiographic Abnormalities in Inflammatory Bowel Disease. Bhutani, Manoop S. // American Journal of Gastroenterology;Oct1993, Vol. 88 Issue 10, p1804 

    Presents a letter to the editor about electrocardiographic abnormalities in inflammatory bowel disease.

  • Inflammatory biomarkers predict relapse in IBD. Hanaway, P.; Roseth, A. // Gut;Sep2005, Vol. 54 Issue 9, p1346 

    Presents a letter to the editor about the importance of inflammatory biomarkers in inflammatory bowel disease.

  • Calprotectin and IBD. Lemann, M.; J. Y.Mary // Gut;Sep2005, Vol. 54 Issue 9, p1349 

    Presents a letter to the editor about the role of calprotectin in treating inflammatory bowel disease patients.

  • Helminths as governors of inflammatory bowel disease. Büning, J.; Homann, N.; Von Smolinski, D.; Borcherding, F.; Noack, F.; Stolte, M.; Kohl, M.; Lehnert, H.; Ludwig, D. // Gut;Aug2008, Vol. 57 Issue 8, p1182 

    A letter to the editor is presented in response to the article "Helminths as governors of inflammatory bowel disease" which was published in a previous issue of the periodical.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics